Acuta Capital Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-425,128
| Closed | -$9.82M | – | 39 |
|
|
2023
Q4 | $9.82M | Buy |
425,128
+125,000
| +42% | +$2.89M | 5.53% | 5 |
|
|
2023
Q3 | $2.4M | Sell |
300,128
-81,872
| -21% | -$654K | 1.61% | 21 |
|
|
2023
Q2 | $3.32M | Buy |
382,000
+78,604
| +26% | +$684K | 2.25% | 18 |
|
|
2023
Q1 | $892K | Hold |
303,396
| – | – | 0.66% | 22 |
|
|
2022
Q4 | $1.06M | Hold |
303,396
| – | – | 0.65% | 25 |
|
|
2022
Q3 | $2.4M | Hold |
303,396
| – | – | 1.03% | 24 |
|
|
2022
Q2 | $2.39M | Sell |
303,396
-4,548
| -1% | -$35.8K | 1.33% | 25 |
|
|
2022
Q1 | $3.74M | Buy |
307,944
+64,872
| +27% | +$788K | 1.75% | 22 |
|
|
2021
Q4 | $2.98M | Sell |
243,072
-126,791
| -34% | -$1.55M | 1.25% | 27 |
|
|
2021
Q3 | $3.85M | Hold |
369,863
| – | – | 1.36% | 23 |
|
|
2021
Q2 | $3.33M | Sell |
369,863
-11,282
| -3% | -$101K | 1.33% | 25 |
|
|
2021
Q1 | $3.87M | Buy |
+381,145
| New | +$3.87M | 1.4% | 31 |
|
|
2015
Q1 | – | Sell |
-12,234
| Closed | -$503K | – | 53 |
|
|
2014
Q4 | $503K | Buy |
+12,234
| New | +$503K | 0.34% | 46 |
|